Learn more about Abbott Laboratories's Revenue by Segment and Revenue by Region.
Check out competitors to Abbott Laboratories in a side-by-side comparison.
Explore additional financial metrics for Abbott Laboratories.
| 2015 | 20405000000.00 |
|---|---|
| 2016 | 20853000000.00 |
| 2017 | 27390000000.00 |
| 2018 | 30578000000.00 |
| 2019 | 31904000000.00 |
| 2020 | 34608000000.00 |
| 2021 | 43075000000.00 |
| 2022 | 43653000000.00 |
| 2023 | 40109000000.00 |
| 2024 | 41950000000.00 |
| 2025 | 44328000000.00 |
| Mar 2016 | 4885000000.00 |
|---|---|
| Jun 2016 | 5333000000.00 |
| Sep 2016 | 5302000000.00 |
| Dec 2016 | 5333000000.00 |
| Mar 2017 | 6335000000.00 |
| Jun 2017 | 6637000000.00 |
| Sep 2017 | 6829000000.00 |
| Dec 2017 | 7589000000.00 |
| Mar 2018 | 7390000000.00 |
| Jun 2018 | 7767000000.00 |
| Sep 2018 | 7656000000.00 |
| Dec 2018 | 7765000000.00 |
| Mar 2019 | 7535000000.00 |
| Jun 2019 | 7979000000.00 |
| Sep 2019 | 8076000000.00 |
| Dec 2019 | 8314000000.00 |
| Mar 2020 | 7726000000.00 |
| Jun 2020 | 7328000000.00 |
| Sep 2020 | 8853000000.00 |
| Dec 2020 | 10701000000.00 |
| Mar 2021 | 10456000000.00 |
| Jun 2021 | 10223000000.00 |
| Sep 2021 | 10928000000.00 |
| Dec 2021 | 11468000000.00 |
| Mar 2022 | 11895000000.00 |
| Jun 2022 | 11257000000.00 |
| Sep 2022 | 10410000000.00 |
| Dec 2022 | 10091000000.00 |
| Mar 2023 | 9747000000.00 |
| Jun 2023 | 9978000000.00 |
| Sep 2023 | 10143000000.00 |
| Dec 2023 | 10241000000.00 |
| Mar 2024 | 9964000000.00 |
| Jun 2024 | 10377000000.00 |
| Sep 2024 | 10635000000.00 |
| Dec 2024 | 10974000000.00 |
| Mar 2025 | 10358000000.00 |
| Jun 2025 | 11142000000.00 |
| Sep 2025 | 11369000000.00 |
| Dec 2025 | 11459000000.00 |
| Mar 2026 | 11164000000.00 |
Abbott Laboratories's annual revenue was $44.33 B in fiscal year 2025.
Abbott Laboratories's quarterly revenue was $10.36 B(Q1: Mar 2025), $11.14 B(Q2: Jun 2025), $11.37 B(Q3: Sep 2025), $11.46 B(Q4: Dec 2025) in fiscal year 2025.
Abbott Laboratories's annual revenue was $41.95 B in fiscal year 2024.
Abbott Laboratories's quarterly revenue was $9.96 B(Q1: Mar 2024), $10.38 B(Q2: Jun 2024), $10.64 B(Q3: Sep 2024), $10.97 B(Q4: Dec 2024) in fiscal year 2024.
Abbott Laboratories's annual revenue was $40.11 B in fiscal year 2023.
Abbott Laboratories's quarterly revenue was $9.75 B(Q1: Mar 2023), $9.98 B(Q2: Jun 2023), $10.14 B(Q3: Sep 2023), $10.24 B(Q4: Dec 2023) in fiscal year 2023.
Abbott Laboratories's annual revenue was $43.65 B in fiscal year 2022.
Abbott Laboratories's quarterly revenue was $11.90 B(Q1: Mar 2022), $11.26 B(Q2: Jun 2022), $10.41 B(Q3: Sep 2022), $10.09 B(Q4: Dec 2022) in fiscal year 2022.
Abbott Laboratories's annual revenue was $43.08 B in fiscal year 2021.
Abbott Laboratories's quarterly revenue was $10.46 B(Q1: Mar 2021), $10.22 B(Q2: Jun 2021), $10.93 B(Q3: Sep 2021), $11.47 B(Q4: Dec 2021) in fiscal year 2021.
Abbott Laboratories's annual revenue was $34.61 B in fiscal year 2020.
Abbott Laboratories's quarterly revenue was $7.73 B(Q1: Mar 2020), $7.33 B(Q2: Jun 2020), $8.85 B(Q3: Sep 2020), $10.70 B(Q4: Dec 2020) in fiscal year 2020.
Abbott Laboratories's annual revenue was $31.90 B in fiscal year 2019.
Abbott Laboratories's quarterly revenue was $7.54 B(Q1: Mar 2019), $7.98 B(Q2: Jun 2019), $8.08 B(Q3: Sep 2019), $8.31 B(Q4: Dec 2019) in fiscal year 2019.
Abbott Laboratories's annual revenue was $30.58 B in fiscal year 2018.
Abbott Laboratories's quarterly revenue was $7.39 B(Q1: Mar 2018), $7.77 B(Q2: Jun 2018), $7.66 B(Q3: Sep 2018), $7.77 B(Q4: Dec 2018) in fiscal year 2018.
Abbott Laboratories's annual revenue was $27.39 B in fiscal year 2017.
Abbott Laboratories's quarterly revenue was $6.34 B(Q1: Mar 2017), $6.64 B(Q2: Jun 2017), $6.83 B(Q3: Sep 2017), $7.59 B(Q4: Dec 2017) in fiscal year 2017.
Abbott Laboratories's annual revenue was $20.85 B in fiscal year 2016.
Abbott Laboratories's quarterly revenue was $4.89 B(Q1: Mar 2016), $5.33 B(Q2: Jun 2016), $5.30 B(Q3: Sep 2016), $5.33 B(Q4: Dec 2016) in fiscal year 2016.
| 2015 | 0 |
|---|---|
| 2016 | +2.20 |
| 2017 | +31.35 |
| 2018 | +11.64 |
| 2019 | +4.34 |
| 2020 | +8.48 |
| 2021 | +24.47 |
| 2022 | +1.34 |
| 2023 | -8.12 |
| 2024 | +4.59 |
| 2025 | +5.67 |
| Q1: Mar 16 | -0.25 |
|---|---|
| Q2: Jun 16 | 3.15 |
| Q3: Sep 16 | 2.95 |
| Q4: Dec 16 | 2.79 |
| Q1: Mar 17 | 29.68 |
| Q2: Jun 17 | 24.45 |
| Q3: Sep 17 | 28.80 |
| Q4: Dec 17 | 42.30 |
| Q1: Mar 18 | 16.65 |
| Q2: Jun 18 | 17.03 |
| Q3: Sep 18 | 12.11 |
| Q4: Dec 18 | 2.32 |
| Q1: Mar 19 | 1.96 |
| Q2: Jun 19 | 2.73 |
| Q3: Sep 19 | 5.49 |
| Q4: Dec 19 | 7.07 |
| Q1: Mar 20 | 2.53 |
| Q2: Jun 20 | -8.16 |
| Q3: Sep 20 | 9.62 |
| Q4: Dec 20 | 28.71 |
| Q1: Mar 21 | 35.34 |
| Q2: Jun 21 | 39.51 |
| Q3: Sep 21 | 23.44 |
| Q4: Dec 21 | 7.17 |
| Q1: Mar 22 | 13.76 |
| Q2: Jun 22 | 10.11 |
| Q3: Sep 22 | -4.74 |
| Q4: Dec 22 | -12.01 |
| Q1: Mar 23 | -18.06 |
| Q2: Jun 23 | -11.36 |
| Q3: Sep 23 | -2.56 |
| Q4: Dec 23 | 1.49 |
| Q1: Mar 24 | 2.23 |
| Q2: Jun 24 | 4.00 |
| Q3: Sep 24 | 4.85 |
| Q4: Dec 24 | 7.16 |
| Q1: Mar 25 | 3.95 |
| Q2: Jun 25 | 7.37 |
| Q3: Sep 25 | 6.90 |
| Q4: Dec 25 | 4.42 |
| Q1: Mar 26 | 7.78 |
Abbott Laboratories’s annual revenue increased +5.67% during fiscal year 2025 compared to 2024. It represents a growth of $2.38 B from $41.95 B (in 2024) to $44.33 B (in 2025).
Abbott Laboratories’s annual revenue increased +4.59% during fiscal year 2024 compared to 2023. It represents a growth of $1.84 B from $40.11 B (in 2023) to $41.95 B (in 2024).
Abbott Laboratories’s annual revenue decreased -8.12% during fiscal year 2023 compared to 2022. It represents a decline of $3.54 B from $43.65 B (in 2022) to $40.11 B (in 2023).
Abbott Laboratories’s annual revenue increased +1.34% during fiscal year 2022 compared to 2021. It represents a growth of $578.00 M from $43.08 B (in 2021) to $43.65 B (in 2022).
Abbott Laboratories’s annual revenue increased +24.47% during fiscal year 2021 compared to 2020. It represents a growth of $8.47 B from $34.61 B (in 2020) to $43.08 B (in 2021).
Abbott Laboratories’s annual revenue increased +8.48% during fiscal year 2020 compared to 2019. It represents a growth of $2.70 B from $31.90 B (in 2019) to $34.61 B (in 2020).
Abbott Laboratories’s annual revenue increased +4.34% during fiscal year 2019 compared to 2018. It represents a growth of $1.33 B from $30.58 B (in 2018) to $31.90 B (in 2019).
Abbott Laboratories’s annual revenue increased +11.64% during fiscal year 2018 compared to 2017. It represents a growth of $3.19 B from $27.39 B (in 2017) to $30.58 B (in 2018).
Abbott Laboratories’s annual revenue increased +31.35% during fiscal year 2017 compared to 2016. It represents a growth of $6.54 B from $20.85 B (in 2016) to $27.39 B (in 2017).
Abbott Laboratories’s annual revenue increased +2.20% during fiscal year 2016 compared to 2015. It represents a growth of $448.00 M from $20.41 B (in 2015) to $20.85 B (in 2016).
Sign in to download table
| Period | Revenue | Year-over-Year Change |
|---|---|---|
|
Get instant access to data, Sign up for free
FY 2025
|
$44.33 B |
$2.38 B
|
| Q4: Dec 25 | $11.46 B |
$485.00 M
|
| Q3: Sep 25 | $11.37 B |
$734.00 M
|
| Q2: Jun 25 | $11.14 B |
$765.00 M
|
| Q1: Mar 25 | $10.36 B |
$394.00 M
|
|
Get instant access to data, Sign up for free
FY 2024
|
$41.95 B |
$1.84 B
|
| Q4: Dec 24 | $10.97 B |
$733.00 M
|
| Q3: Sep 24 | $10.64 B |
$492.00 M
|
| Q2: Jun 24 | $10.38 B |
$399.00 M
|
| Q1: Mar 24 | $9.96 B |
$217.00 M
|
|
Get instant access to data, Sign up for free
FY 2023
|
$40.11 B |
-$3.54 B
|
| Q4: Dec 23 | $10.24 B |
$150.00 M
|
| Q3: Sep 23 | $10.14 B |
-$267.00 M
|
| Q2: Jun 23 | $9.98 B |
-$1.28 B
|
| Q1: Mar 23 | $9.75 B |
-$2.15 B
|
|
Get instant access to data, Sign up for free
FY 2022
|
$43.65 B |
$578.00 M
|
| Q4: Dec 22 | $10.09 B |
-$1.38 B
|
| Q3: Sep 22 | $10.41 B |
-$518.00 M
|
| Q2: Jun 22 | $11.26 B |
$1.03 B
|
| Q1: Mar 22 | $11.90 B |
$1.44 B
|
|
Get instant access to data, Sign up for free
FY 2021
|
$43.08 B |
$8.47 B
|
| Q4: Dec 21 | $11.47 B |
$767.00 M
|
| Q3: Sep 21 | $10.93 B |
$2.08 B
|
| Q2: Jun 21 | $10.22 B |
$2.90 B
|
| Q1: Mar 21 | $10.46 B |
$2.73 B
|
|
Get instant access to data, Sign up for free
FY 2020
|
$34.61 B |
$2.70 B
|
| Q4: Dec 20 | $10.70 B |
$2.39 B
|
| Q3: Sep 20 | $8.85 B |
$777.00 M
|
| Q2: Jun 20 | $7.33 B |
-$651.00 M
|
| Q1: Mar 20 | $7.73 B |
$191.00 M
|
|
Get instant access to data, Sign up for free
FY 2019
|
$31.90 B |
$1.33 B
|
| Q4: Dec 19 | $8.31 B |
$549.00 M
|
| Q3: Sep 19 | $8.08 B |
$420.00 M
|
| Q2: Jun 19 | $7.98 B |
$212.00 M
|
| Q1: Mar 19 | $7.54 B |
$145.00 M
|
|
Get instant access to data, Sign up for free
FY 2018
|
$30.58 B |
$3.19 B
|
| Q4: Dec 18 | $7.77 B |
$176.00 M
|
| Q3: Sep 18 | $7.66 B |
$827.00 M
|
| Q2: Jun 18 | $7.77 B |
$1.13 B
|
| Q1: Mar 18 | $7.39 B |
$1.06 B
|
|
Get instant access to data, Sign up for free
FY 2017
|
$27.39 B |
$6.54 B
|
| Q4: Dec 17 | $7.59 B |
$2.26 B
|
| Q3: Sep 17 | $6.83 B |
$1.53 B
|
| Q2: Jun 17 | $6.64 B |
$1.30 B
|
| Q1: Mar 17 | $6.34 B |
$1.45 B
|
|
Get instant access to data, Sign up for free
FY 2016
|
$20.85 B |
$448.00 M
|
| Q4: Dec 16 | $5.33 B |
$145.00 M
|
| Q3: Sep 16 | $5.30 B |
$152.00 M
|
| Q2: Jun 16 | $5.33 B |
$163.00 M
|
| Q1: Mar 16 | $4.89 B |
-$12.00 M
|
In fiscal year 2025, Abbott Laboratories's revenue was $44.33 Billion.
Abbott Laboratories's revenue increased by +5.67% (+$2.38 Billion) in 2025 compared to 2024.
In the first quarter (Q1) of 2026, Abbott Laboratories reported a revenue of $11.16 Billion.
Abbott Laboratories's revenue per share over the trailing twelve months is $25.84.
In the fiscal year 2025, Abbott Laboratories's revenue per employee was $385.46 K.
In fiscal year 2025, Abbott Laboratories's net income was $6.52 Billion.
Medical Devices is Abbott Laboratories's biggest product segment, generating $21.39 Billion in revenue for fiscal year 2025.
In the fiscal year 2025, Abbott Laboratories's net income per employee was $56.73 K.